The importance of betting on outcomes, not simply risk sharing, when implementing pharma-payer arrangements. .
Urs Wiedemann
Advertisement
Articles by Urs Wiedemann
Advertisement
Latest Updated Articles
Raising the Stakes On Value-Based PricingPublished: April 12th 2016 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Bayer’s Lynkuet as First Dual Neurokinin Antagonist for Menopausal Hot Flashes
2
Direct-to-patient: pharma’s next power move
3
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
4
AI Becomes Pharma’s New Operating System: Q&A with causaLens’ CEO and Co-Founder Darko Matovski
5
